TD Cowen began coverage on shares of Palvella Therapeutics (NASDAQ:PVLA – Free Report) in a research report released on Wednesday morning, MarketBeat.com reports. The firm issued a buy rating and a ...

We recently published a list of 9 Trending AI News Updates on Wall Street’s Radar. In this article, we are going to take a ...

As previously reported last night, Cantor Fitzgerald analyst Colin Canfield initiated coverage of five Government Technology & Space, or ...

Cantor Fitzgerald reaffirmed its Overweight rating on Neurocrine Biosciences stock (NASDAQ:NBIX) with a consistent price target of $170.00. Currently trading at $150.51, the stock has shown strong ...

Will the Senate GOP confirm controversial picks like Tulsi Gabbard and RFK Jr.? Here’s the hearings schedule and list of ...

Cantor Fitzgerald analyst Deepak Mathivanan maintained a Buy rating on Pinterest (PINS – Research Report) today and set a price target of ...

It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...

We recently published a list of 15 Hot Tech Stocks to Buy Right Now. In this article, we are going to take a look at where ...

Analysts at Cantor Fitzgerald lowered their FY2025 EPS estimates for shares of PTC Therapeutics in a report released on ...

Soleo provides high-touch specialty pharmacy and infusion services to over 22,000 patients annually nationwide via a network ...